| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 02/22/2006 | EP1626696A2 Novel fibroblast growth factors and methods of use thereof |
| 02/22/2006 | EP1626695A2 Compositions and methods for reducing scar tissue formation |
| 02/22/2006 | EP1626694A2 Vaccine accelerator factor (vaf) for improvement of vaccinations in poultry |
| 02/22/2006 | EP1626693A2 Ginkgo biloba extract as a treatment for therapeutic- induced neurotoxicity |
| 02/22/2006 | CN1738801A Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
| 02/22/2006 | CN1738651A Contrast media formulations having improved biological tolerance |
| 02/22/2006 | CN1738645A Antilymphoma targeting agents with effector and affinity functions linked by a trifunctional reagent |
| 02/22/2006 | CN1738643A Composition and method for preventing or treating a virus infection |
| 02/22/2006 | CN1738634A Extract of stephaniae sinica diels and methods of using the same |
| 02/22/2006 | CN1738617A Pharmaceutical compositions for the prevention or treatment of cardiovascular, cardiopulmonary, pulmonary or renal diseases |
| 02/22/2006 | CN1738599A Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds |
| 02/22/2006 | CN1736995A Method for preparing derivatives of baccatin iii |
| 02/22/2006 | CN1736985A Growth hormone secretagogues |
| 02/22/2006 | CN1736487A Bioimplant formulation |
| 02/22/2006 | CN1736377A Novel composition and use |
| 02/21/2006 | US7002159 Boron coated straw neutron detector |
| 02/21/2006 | US7002030 Substance for lowering high cholesterol level in serum and methods for preparing and using the same |
| 02/21/2006 | US7002022 treatment of neoplastic diseases that respond to inhibition of the vascular endothelial growth factor receptor tyrosine kinase activity; tumors, retinopathy, macular degeneration |
| 02/21/2006 | US7001983 Non-hemolytic cytolytic peptides;antibacterial, anticancer, antiprotozoal agents |
| 02/21/2006 | US7001926 Tubulin binding agents and corresponding prodrug constructs |
| 02/21/2006 | US7001923 Taxol enhancer compounds |
| 02/21/2006 | US7001908 Arylpiperazines having activity at the serotonin 1A receptor |
| 02/21/2006 | US7001894 Blood flow improvers and thrombosis preventives or remedies |
| 02/21/2006 | CA2423825C New perindopril salt and pharmaceutical compounds containing it |
| 02/16/2006 | WO2005055941A3 Novel m3 muscarinic acetylcholine receptor antagonists |
| 02/16/2006 | WO2005048957A3 Novel insertion sites in pox vectors |
| 02/16/2006 | WO2005044183A3 Methods and compositions using adiponectin for treatment of cardiac disorders and for stimulation of angiogenesis |
| 02/16/2006 | WO2005037191A3 Expression of dominant negative transmembrane receptors in the milk of transgenic animals |
| 02/16/2006 | WO2005032455A8 Combinatorially selected phosphorodithioate aptamer targeting ap-1 |
| 02/16/2006 | WO2005027820A3 System and method of aneurism monitoring and treatment |
| 02/16/2006 | WO2005020916A3 Myoblast treatment of diseased or weakened organs |
| 02/16/2006 | WO2005016251A3 Mutations in the cystic fibrosis gene |
| 02/16/2006 | WO2005009332A3 Compositions-of-matter for lowering serum cholesterol and/or triglyceride level and methods of producing and using same |
| 02/16/2006 | WO2005007123A3 Pin1-modulating compounds and methods of use thereof |
| 02/16/2006 | WO2005002525A3 Cox-2 and faah inhibitors |
| 02/16/2006 | WO2004112729A3 Dual function compounds and uses thereof |
| 02/16/2006 | WO2004110378A3 Treatment alzheimer's disease with r(-) 2-arylproponic acid nsaid alone or in combination with selective cox-2 inhibitor |
| 02/16/2006 | WO2004110359A9 Fusion proteins for the treatment of cns |
| 02/16/2006 | WO2004091491A3 Profiling conformational variants, antibody compositions and methods of using the same |
| 02/16/2006 | WO2004089285A3 Phosphodiesterase 2a and methods of use |
| 02/16/2006 | WO2004082599A3 Combination of an aldosterone receptor antagonist and an anti-diabetic agent |
| 02/16/2006 | WO2004071430A3 RNAi TARGETING OF VIRUSES |
| 02/16/2006 | WO2004047720A3 Methods of inhibiting angiogensis via modification of a lysyl oxidase |
| 02/16/2006 | WO2004043384A3 Novel pharmacophore for the discovery and testing of na, k-atpase inhibitor compositions and methods for their use in treating cardiovascular diseases and conditions |
| 02/16/2006 | US20060036076 Metalloproteinase-binding proteins |
| 02/16/2006 | US20060036057 Phosphoric ester demulsifier composition |
| 02/16/2006 | US20060035980 Thyronamine derivatives and analogs and methods of use thereof |
| 02/16/2006 | US20060035958 Method of treating diabetes and related conditions |
| 02/16/2006 | US20060035929 Compositions and methods containing substituted quinolines and substituted diphenylsulfones |
| 02/16/2006 | US20060035885 8-Substituted-6,7,8,9-tetrahydropyrimido [1,2-a] pyrimidin-4-one derivatives |
| 02/16/2006 | US20060035825 Alpha 5 beta 1 and its ability to regulate the cell survival pathway |
| 02/16/2006 | US20060035813 Methods and formulations comprising agonists and antagonists of nuclear hormone receptors |
| 02/16/2006 | US20060035811 Methods of treating dry eye disease with lantibiotics |
| 02/16/2006 | US20060035285 Method for identifying modulators of human orexin-2 receptor |
| 02/16/2006 | US20060034928 Tablet comprising cetirizine and pseudoephedrine |
| 02/16/2006 | US20060034835 Immunoglobulin variants and uses thereof |
| 02/16/2006 | US20060034811 Melanoma vaccine and methods of making and using same |
| 02/15/2006 | EP1625140A2 Branched immunomodulatory compounds and methods of using the same |
| 02/15/2006 | EP1625123A2 3-(2-amino-1-azacyclyl)-5-aryl-1,2,4-oxadiazoles as s1p receptor agonists |
| 02/15/2006 | EP1625111A2 Thyronamine derivatives and analogs and methods of use thereof |
| 02/15/2006 | EP1624899A2 Increased transduction using abc transporter substrates and/or inhibitors |
| 02/15/2006 | EP1624892A2 Therapeutic use of anti-cs1 antibodies |
| 02/15/2006 | EP1624889A2 Compositions for inducing immune responses |
| 02/15/2006 | EP1624884A2 Somatostatin vectors |
| 02/15/2006 | EP1624883A2 Compositions and methods related to production of erythropoietin |
| 02/15/2006 | EP1624879A2 Method and composition for preventing, reducing and reversing ocular ischemic neuronal damage |
| 02/15/2006 | EP1624874A2 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 02/15/2006 | EP1624859A2 Method for preparing thermoformed compositions containing acrylic polymer binders, pharmaceutual dosage forms and methods of preparing the same |
| 02/15/2006 | EP1624855A2 Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs |
| 02/15/2006 | EP1624849A2 Methionine aminopeptidase and methods of use |
| 02/15/2006 | EP1624847A2 Compositions and methods for the preparation of human growth hormone glycosylation mutants |
| 02/15/2006 | EP1624846A2 Inhibition of drug binding to serum albumin |
| 02/15/2006 | EP1624844A2 Morinda citrifolia-based formulation for inhibiting metastasis of carcinogenic cells |
| 02/15/2006 | EP1624843A2 Hemorrhoid treatment device |
| 02/15/2006 | EP1624837A2 Apparatus and method for the treatment of infectious disease in keratinized tissue |
| 02/15/2006 | CN1735630A Therapeutic polypeptides, homologues thereof, fragments thereof and for use in modulating platelet-mediated aggregation |
| 02/15/2006 | CN1735419A Extract of trapa natans and methods of using the same |
| 02/15/2006 | CN1735407A Methods of using and compositions comprising dopamine reuptake inhibitors |
| 02/15/2006 | CN1735404A Medical devices employing novel polymers |
| 02/15/2006 | CN1733725A Process for preparing 2-iminopyrrolidine derivatives |
| 02/15/2006 | CN1241651C Hemostatic antibiotic products and preparing method thereof |
| 02/15/2006 | CN1241644C Vaccine formulation potentiated by combination of DNA and an antigen |
| 02/14/2006 | US6998142 Composition and method for the prevention and treatment of asthma |
| 02/14/2006 | US6998137 Proteins deposited onto sparingly soluble biocompatible particles for controlled protein release into a biological environment from a polymer matrix |
| 02/14/2006 | US6997909 Low profile combination device for gastrostomy or jejunostomy applications having anti-granuloma formation characteristics |
| 02/14/2006 | CA2374643C 1-trifluoromethyl-4-hydroxy-7-piperidinylaminomethylchroman derivatives as substance p antagonists |
| 02/09/2006 | WO2005120436A3 Composition for treating post-surgical pain |
| 02/09/2006 | WO2005058238A3 Antimicrobial composition |
| 02/09/2006 | WO2005027825A3 Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus |
| 02/09/2006 | WO2005004811A3 Self-crosslinkable poly(caprolactone fumarate) |
| 02/09/2006 | WO2004091494A3 Method for preparation of site-specific protein conjugates |
| 02/09/2006 | WO2004032830A3 Targeted glycosaminoglycan polymers by polymer grafting and methods of making and using same |
| 02/09/2006 | WO2004028478A3 Functional mutations in respiratory syncytial virus |
| 02/09/2006 | WO2003105761A3 Immunotoxin as a therapeutic agent and uses thereof |
| 02/09/2006 | US20060030873 Nosebleed lip pack |
| 02/09/2006 | US20060030560 Pyrimidine compounds |
| 02/09/2006 | US20060029668 Sustained release L-arginine formulations and methods of manufacture and use |
| 02/09/2006 | US20060029593 Immunoglobulins having complementarity determining regions, heavy and light chain variable regions from humans that specifically bind to an antigen with affinity, used for in vivo therapy and diagnosis |
| 02/09/2006 | US20060029587 For patients undergoing or who have undergone a surgical a daily nutritional supplement comprising coenzyme Q10; L-cystine; L-glutamine; L-lysine; Vitamin C; Vitamin A; about 100 Vitamin D; Vitamin B1; Vitamin B2; Vitamin B5; Vitamin B6; folic acid; calcium, selenium and zinc |
| 02/09/2006 | US20060029555 Caffeine, theophylline, theobromine and free radical scavenger; topically applied to the skin of an individual with heightened sensitivity to the sun |